iShares Biotechnology ETF (IBB)
| 135.60 Delayed Data As of Feb 06 |  -0.98 / -0.72%Today’s Change | 104.29 Today|||52-Week Range 138.74 | +3.28% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Latest IBB News
No recent news for iShares Biotechnology ETF.
Performance
| 1 month | +4.88% | 3 years | +5.89% | |
| 3 months | +6.81% | 5 years | +4.24% | |
| 1 year | +5.23% | Since inception | +6.80% |
Data through 02/04/2023
Quote Details
| Previous close | $136.59 |
| Open day’s range | 135.26 – 137.27 |
| Net asset value (NAV) | 136.53 (02/03/2023) |
| Daily volume | 1,478,445 |
| Average volume (3 months) | 1,805,932 |
Data as of 3:59pm ET, 02/06/2023
Peer Comparisonvs. Health ETFs
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +4.24% | +7.62% |
| Expense Gross exp ratio | 0.44% | 1.01% |
| Risk 5 year sharpe ratio | 0.22 | 0.38 |
| Net assets | $9.0B | $2.0B |
| Average market cap | $21.2B | $52.3B |
| Average P/E | 16.3 | 23.6 |
| Dividend / Share | -- | 0.22% |
Competitors
| FHLC Fidelity MSCI Health Care Index ETF |
| VHT Vanguard Health Care Index Fund ETF Shar... |
| RYH Invesco S&P 500® Equal Weight Health Ca... |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| GILD Gilead Sciences | 7.62% |
| VRTX Vertex Pharmaceuticals Inc | 7.61% |
| REGN Regeneron Pharmaceuticals | 7.15% |
| AMGN Amgen | 7.03% |
| MRNA Moderna Inc | 5.36% |
| IQV IQVIA Holdings Inc | 3.89% |
| BIIB Biogen | 3.80% |
| MTD Mettler-Toledo International Inc | 3.10% |
| ILMN Illumina Inc | 3.09% |
| ALNY Alnylam Pharmaceuticals Inc | 2.54% |
